Navigation Links
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
Date:5/6/2009

CONFERENCE CALL

The company has scheduled a conference call for tomorrow, Thursday, May 7, 2009 at 10:30 AM ET. During the call, Mihael H. Polymeropoulos, M.D., President and CEO and Stephanie R. Irish, Acting Chief Financial Officer, will discuss the FDA's approval of Fanapt(TM). Investors can call 1-866-314-4865 (domestic) and 1-617-213-8050 (international) prior to the 10:30 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos. A replay of the call will be available Thursday, May 7, 2009, at 1:30 PM ET and will be accessible until Thursday, May 14, 2009, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 55054292.

The conference call will be broadcast simultaneously on the company's Web site, http://www.vandapharma.com. Investors should click on the Investor Relations tab and are advised to go to the Web site at least 15 minutes early to register, download, and install any necessary software. The call will also be archived on the Vanda Web site for a period of 30 days, through June 6, 2009.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Various statements in this release are "forward-looking statements" under the securities laws. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," and "could," and similar expressions or words, identify forward-looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Vanda Pharmaceuticals Inc. is at an early stage of development and may not ever have any products that generate significant revenue. Important factors that could cause actual results to dif
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
2. FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
3. FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
4. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
5. FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
6. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
7. F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
8. FDA Approves First Hepatitis B Viral Load Test
9. U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinsons Disease
10. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
11. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... NAMUR , Belgium , July ... MKT: VNRX), a life sciences company focused on developing ... types and other conditions, today announced that it has ... research organization, Global Specimen Solutions, Inc. (GSS), to support ... colorectal cancer tests. Under the agreement, ...
(Date:7/27/2015)... DUBLIN , July 27, 2015 Research ... of the "Intraoperative Imaging Market by Type (Intraoperative ... America, Europe, Asia-Pacific, ROW) - Global Forecast to 2019" ... market is expected to reach a value of $2.1 ... a CAGR of 3.5% during the forecast period. ...
(Date:7/27/2015)... 2015   Iagnosis , the creator of ... online dermatology solutions, announced today its 2015 year-to-date ... has contractual relationships with dermatologists in 30 states, ... Dermatologists and Extenders Since December 2014, the ... of providers delivering care through the platform, which ...
Breaking Medicine Technology:VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2Iagnosis Reports Significant Growth YTD 2015 2
... Jan. 13, 2011 Baylor Health Care System is ... quality of patient care in North Texas through the ... health care system.  It is one of thousands of ... with the U.S. Department of Health and Human Services ...
... 13, 2011 Dendreon Corporation (Nasdaq: DNDN ) ... other conditions, $500 million aggregate principal amount of convertible senior ... registered under the Securities Act of 1933, as amended (the ... of Dendreon,s common stock (the "Common Stock") or a combination ...
Cached Medicine Technology:Baylor Health Care System Registers its Commitment to Achieve Meaningful Use of the Electronic Health Record 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 3Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 4
(Date:7/27/2015)... , ... July 27, 2015 , ... With a new ... with PursuitSAFETY to support its mission of reducing the number of deaths and injuries ... support victims and their families. PursuitSAFETY works with the police to find better ...
(Date:7/27/2015)... , ... July 27, 2015 , ... For a limited ... promotion on Zoom teeth whitening. Summer is a great time to change up a ... reasons, but discolored teeth can really affect your self-esteem. Over time, the enamel coating ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... fullerenes in medical and diagnostics applications is rapidly increasing and is driven by ... cancer treatment, they are increasingly being evaluated for use in bio implants. MWCNTs ...
(Date:7/27/2015)... ... 27, 2015 , ... The Advocator Group, LLC, a nationwide ... Cogswell as the vice president of client services. Mr. Cogswell has over twenty ... role in the growth and transformation of several businesses, including Bob’s Discount Furniture ...
(Date:7/27/2015)... ... 27, 2015 , ... Premier Insurance Advisors, a full service ... charity and awareness event with the Houston chapter of NAMI, the National Alliance ... to bettering the lives of the millions of Americans affected by mental illness. ...
Breaking Medicine News(10 mins):Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 3Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 2Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 3Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 2Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 3Health News:Premier Insurance and the National Alliance of Mental Health Launch Grassroots Charity Effort to Support Houston Residents with Developmental Challenges 2Health News:Premier Insurance and the National Alliance of Mental Health Launch Grassroots Charity Effort to Support Houston Residents with Developmental Challenges 3
... from NIDCR have created an animal model that ... II and dentin dysplasia. Dr. Ashok Kulkarni and ... amounts of TGF-b1 (transforming growth factor beta-1) in ... apparent defects, but at two weeks their teeth ...
... researchers people who sleep for more or less than seven ... over one million adults conducted over a six year time ... hours sleep a night might need modifying. Looking at the ... expectancy, researchers at the University of Texas, and colleagues, find ...
... an exclusively Western problem. Researchers say weight problems ... in developing nations, particularly children. Until recently, famine ... to the health of poor people in developing ... processing and even leisure time in developing countries ...
... kidney cancer in the UK has risen by 68 per cent ... a year. Research in UK says that 5,700 people each year ... lowest in Europe.// The disease accounts for an estimated 95,000 worldwide ... ,According to Dr Nick James, a consultant at the Queen Elizabeth ...
... conduct tests for any Indian doctor having graduated abroad avid ... higher standards amongst doctors, the government has made it compulsory ... today. , The new regulations, ... students who want to enrol in MBBS course abroad will ...
... men tend to die younger than married ones. Psychiatrists ... health by giving them emotional ward.// ,Researchers in ... heart disease and stroke were higher in unmarried men ... in death rates between married and unmarried women. ...
Cached Medicine News:Health News:Heriditary dental disorders 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: